Antigiardial Effect of Kramecyne in Experimental Giardiasis

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2018 Feb 2

PMID 29387130

Citations 2

Authors

Leticia Eligio-Garcia

Elida Pontifez-Pablo

Salud Perez-Gutierrez

Enedina Jimenez-Cardoso

Affiliations

Soon will be listed here.

Abstract

A variety of drugs are used in giardiasis treatment with different levels of efficiency, presence of side effects, and even formation of resistant strains, so that it is important to search new only-one-dose treatments with high efficiency and less side effects. Kramecyne, an anti-inflammatory compound isolated from methanolic extract of , does not present toxicity, even at doses of 5,000 mg/kg. The objective was to determine the antigiardial effect of kramecyne over and and analyze the expression of genes ERK1, ERK2, and AK on kramecyne treated trophozoites by Real Time Polymerase Chain Reaction (RTPCR). The median lethal dose (LD) was 40 g/mL and no morphological changes were observed by staining with blue trypan and light microscopy; experimental gerbil infection was eliminated with 320 g/Kg of weight. After treatment there were no differences between intestines from treated and untreated gerbils. Kramecyne did not have significant effect over ERK1 and AK, but there are differences in ERK2 expression ( = 0.04). Results show antigiardial activity of kramecyne; however the mode of action is still unclear and the evaluation of ultrastructural damage and expressed proteins is an alternative of study to understand the action mechanism.

Citing Articles

Identification of spp. in Slaughtered Sheep from Spain and Evaluation of Bradyzoite Viability after Freezing.

Peris M, Gracia M, Moreno B, Juan-Puente P, Morales M, Serrano M Vet Sci. 2024; 11(3).

PMID: 38535838 PMC: 10975153. DOI: 10.3390/vetsci11030103.

Preventive role of probiotic bacteria against gastrointestinal diseases in mice caused by Giardia lamblia.

Al-Megrin W, Mohamed S, Saleh M, Yehia H Biosci Rep. 2021; 41(2).

PMID: 33600560 PMC: 7901011. DOI: 10.1042/BSR20204114.

References

Jokipii L, Jokipii A . Comparison of four dosage schedules in the treatment of giardiasis with metronidazole. Infection. 1978; 6(2):92-4. DOI: 10.1007/BF01642166. View

Sanchez-Miranda E, Lemus-Bautista J, Perez S, Perez-Ramos J . Effect of kramecyne on the inflammatory response in lipopolysaccharide-stimulated peritoneal macrophages. Evid Based Complement Alternat Med. 2013; 2013:762020. PMC: 3610359. DOI: 10.1155/2013/762020. View

Murtagh Jr J, Mowatt M, Lee C, Lee F, Mishima K, Nash T . Guanine nucleotide-binding proteins in the intestinal parasite Giardia lamblia. Isolation of a gene encoding an approximately 20-kDa ADP-ribosylation factor. J Biol Chem. 1992; 267(14):9654-62. View

Gilman R, Brown K, Visvesvara G, Mondal G, Greenberg B, Sack R . Epidemiology and serology of Giardia lamblia in a developing country: Bangladesh. Trans R Soc Trop Med Hyg. 1985; 79(4):469-73. DOI: 10.1016/0035-9203(85)90068-9. View

Perez-Gutierrez S, Sanchez-Mendoza E, Martinez-Gonzalez D, Zavala-Sanchez M, Perez-Gonzalez C . Kramecyne--a new anti-inflammatory compound isolated from Krameria cytisoides. Molecules. 2012; 17(2):2049-57. PMC: 6268713. DOI: 10.3390/molecules17022049. View

Lerman S, Walker R . Treatment of giardiasis: literature review and recommendations. Clin Pediatr (Phila). 1982; 21(7):409-14. DOI: 10.1177/000992288202100704. View

Reyes-Vivas H, de la Mora-de la Mora I, Castillo-Villanueva A, Yepez-Mulia L, Hernandez-Alcantara G, Figueroa-Salazar R . Giardial triosephosphate isomerase as possible target of the cytotoxic effect of omeprazole in Giardia lamblia. Antimicrob Agents Chemother. 2014; 58(12):7072-82. PMC: 4249547. DOI: 10.1128/AAC.02900-14. View

Ponce-Macotela M, Rufino-Gonzalez Y, Gonzalez-Maciel A, Reynoso-Robles R, Martinez-Gordillo M . Oregano (Lippia spp.) kills Giardia intestinalis trophozoites in vitro: antigiardiasic activity and ultrastructural damage. Parasitol Res. 2006; 98(6):557-60. DOI: 10.1007/s00436-005-0082-y. View

Keister D . Axenic culture of Giardia lamblia in TYI-S-33 medium supplemented with bile. Trans R Soc Trop Med Hyg. 1983; 77(4):487-8. DOI: 10.1016/0035-9203(83)90120-7. View

10.

Sullivan P, DuPont H, Arafat R, Thornton S, Selwyn B, El Alamy M . Illness and reservoirs associated with Giardia lamblia infection in rural Egypt: the case against treatment in developing world environments of high endemicity. Am J Epidemiol. 1988; 127(6):1272-81. DOI: 10.1093/oxfordjournals.aje.a114919. View

11.

Bowers M . Nitazoxanide for cryptosporidial diarrhea. BETA. 2001; :30-1. View

12.

Sauch J . Purification of Giardia muris cysts by velocity sedimentation. Appl Environ Microbiol. 1984; 48(2):454-5. PMC: 241540. DOI: 10.1128/aem.48.2.454-455.1984. View

13.

Gilman R, Marquis G, Miranda E, Vestegui M, Martinez H . Rapid reinfection by Giardia lamblia after treatment in a hyperendemic Third World community. Lancet. 1988; 1(8581):343-5. DOI: 10.1016/s0140-6736(88)91131-2. View

14.

Arevalo A, Duque S, Nicholls R . [Experimental infection of the gerbil (Meriones unguiculatus) by Colombian isolates of Giardia duodenalis]. Biomedica. 2005; 25(3):305-14. View

15.

Craft J . Experimental infection with Giardia lamblia in rats. J Infect Dis. 1982; 145(4):495-8. DOI: 10.1093/infdis/145.4.495. View

16.

Vidal F, Vidal J, Gadelha A, Lopes C, Coelho M, Monteiro-Leal L . Giardia lamblia: the effects of extracts and fractions from Mentha x piperita Lin. (Lamiaceae) on trophozoites. Exp Parasitol. 2006; 115(1):25-31. DOI: 10.1016/j.exppara.2006.05.001. View

17.

Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth B, Remm M . Primer3--new capabilities and interfaces. Nucleic Acids Res. 2012; 40(15):e115. PMC: 3424584. DOI: 10.1093/nar/gks596. View

18.

Ellis 4th J, Davila M, Chakrabarti R . Potential involvement of extracellular signal-regulated kinase 1 and 2 in encystation of a primitive eukaryote, Giardia lamblia. Stage-specific activation and intracellular localization. J Biol Chem. 2002; 278(3):1936-45. DOI: 10.1074/jbc.M209274200. View

19.

Lee H, Hyung S, Lee N, Yong T, Han S, Park S . Excretory-secretory products of Giardia lamblia induce interleukin-8 production in human colonic cells via activation of p38, ERK1/2, NF-κB and AP-1. Parasite Immunol. 2012; 34(4):183-98. DOI: 10.1111/j.1365-3024.2012.01354.x. View

20.

Agarwal A, Singh M, Gupta N, Saxena R, Puri A, Verma A . Management of giardiasis by an immuno-modulatory herbal drug Pippali rasayana. J Ethnopharmacol. 1994; 44(3):143-6. DOI: 10.1016/0378-8741(94)01181-8. View